An in-depth look to Ensysce Biosciences Inc. operating, investing, and financing activities

ENSCW free cash flow for Q1 24 is -3.41 M USD. For 2023, ENSCW free cash flow was -10.78 M USD and operating cash flow was -10.78 M USD.